Skip to main navigation Skip to search Skip to main content

The role of hypoxia-inducible factor-2 in digestive system cancers

  • J. Zhao
  • , F. Du
  • , G. Shen
  • , F. Zheng
  • , B. Xu
  • Chinese Academy of Medical Sciences
  • Qinghai University

Research output: Contribution to journalReview articlepeer-review

100 Scopus citations

Abstract

Hypoxia is an all but ubiquitous phenomenon in cancers. Two known hypoxia-inducible factors (HIfs), HIf-1α and HIf-2α, primarily mediate the transcriptional response to hypoxia. Despite the high homology between HIf-1α and HIf-2α, emerging evidence suggests differences between both molecules in terms of transcriptional targets as well as impact on multiple physiological pathways and tumorigenesis. To date, much progress has been made toward understanding the roles of HIf-2α in digestive system cancers. Indeed, HIf-2α has been shown to regulate multiple aspects of digestive system cancers, including cell proliferation, angiogenesis and apoptosis, metabolism, metastasis and resistance to chemotherapy. These findings make HIf-2α a critical regulator of this malignant phenotype. Here we summarize the function of HIf-2 during cancer development as well as its contribution to tumorigenesis in digestive system malignancies.

Original languageEnglish
Article numbere1600
JournalCell Death and Disease
Volume6
Issue number1
DOIs
StatePublished - 1 Jan 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'The role of hypoxia-inducible factor-2 in digestive system cancers'. Together they form a unique fingerprint.

Cite this